10-K/A: Genasys Inc. Files Amendment No. 1 to Form 10-K to Include Conformed Signature

Genasys Inc. has filed an amendment to its annual report on Form 10-K for the fiscal year ended September 30, 2024, solely to include a conformed signature on Exhibit 32.1.

Summary

• Genasys Inc. filed Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended September 30, 2024.
• The amendment was filed to include a conformed signature on Exhibit 32.1, which was inadvertently omitted from the original filing.
• No other changes were made to the Original Form 10-K, and the information remains as of the original filing date.
• The company included updated certifications from the CEO and CFO as required by the Sarbanes-Oxley Act of 2002.
• The aggregate market value of the voting common stock held by nonaffiliates of the registrant as of March 29, 2024 was $88.8 million.

Sentiment

Score: 7

Explanation: The document is a routine amendment to correct a clerical error, indicating standard corporate governance practices. The sentiment is neutral to slightly positive as it reflects attention to detail and compliance.

Positives

• The company is taking corrective action to ensure compliance with SEC filing requirements by including the missing signature.

Future Outlook

The document does not contain any specific forward-looking statements beyond the filing of the proxy statement.

Management Comments

• Richard S. Danforth, Chief Executive Officer, and Dennis D. Klahn, Chief Financial Officer, certified the accuracy and compliance of the report.

Industry Context

This is a standard regulatory filing update, ensuring compliance with SEC requirements. It doesn't provide specific insights into Genasys's competitive position or industry trends.

Stakeholder Impact

• The amendment ensures accurate and complete information is available to shareholders and potential investors.

Next Steps

• The company will file its definitive proxy statement with the Commission pursuant to Regulation 14A in connection with the registrants 2025 Annual Meeting of Stockholders.

Key Dates